Unknown NA INTERVENTIONAL 2-arm NCT03063112

Radiofrequency and Chemical Neurolysis of Thoracic Splanchnic Nerve for Abdominal Cancer Pain (RF)

Comparative Study Between Radiofrequency Thermocoagulation and Chemical Neurolysis of Thoracic Splanchnic Nerve Bilaterally for the Management of Abdominal Cancer Pain

Sponsor: South Egypt Cancer Institute

Conditions Abdominal Cancer

Interventions C arm fluoroscopic device Ethyl alcohol Lidocaine Radiofrequency generator device

Updated 7 times since 2017 Last updated: Feb 26, 2017 Started: Oct 1, 2016 Primary completion: Apr 10, 2017 Completion: May 1, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Abdominal Cancer, this trial is ongoing. The trial is conducted by South Egypt Cancer Institute and has accumulated 7 data snapshots since 2016. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Unknown NA
Sep 2024 — Sep 2025 [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Mar 2019 — Jan 2021 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status

▶ Show 2 earlier versions

Jun 2018 — Mar 2019 [monthly]

Recruiting NA
Mar 2017 — Jun 2018 [monthly]

Recruiting NA

First recorded

Oct 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

South Egypt Cancer Institute

Data source: South Egypt Cancer Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Asyut, Egypt